Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Culture Review.
May 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
5 | 6 | 7 | 8 | 9 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 | 31 |
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
July 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 | 31 |
Press releases published on May 8, 2025

All Pro Capital Expands to Kansas City with New Market Executive Matt Jennings
Colorado Springs, CO, May 08, 2025 (GLOBE NEWSWIRE) -- All Pro Capital is proud to announce the opening of its new Kansas City private equity real estate investments office and the appointment of Kansas native Matt Jennings as Market Executive. This …

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research …

Kamari Pharma Announces Presentations at the 82nd Annual Meeting of the Society for Investigative Dermatology and the International Pachyonychia Congenita Consortium Symposium
Preclinical results presented demonstrate KM-023 is a highly effective and selective oral TRPV3 inhibitor KM-023 normalized cells proliferation and differentiation in 3D pachyonychia congenita skin model and significantly reduced itch behavior and …

Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™
GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced the …

Palvella Therapeutics to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025
WAYNE, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic …

Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2025
Financial Highlights Q2 Performance Driven by Revenue Growth Across Recorded Music and Music Publishing Cost Savings Plans on Track, With Reinvestment Initiatives Accelerating Year-to-Date Operating Cash Flow and Free Cash Flow Increased by 53% and 59%, …

Caliber Announces First Quarter 2025 Earnings Release & Conference Call
SCOTTSDALE, Ariz., May 08, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced that it will release its first quarter 2025 financial results after the close of the market on Thursday, May 15, 2025 …

Dada to Hold Extraordinary General Meeting of Shareholders
SHANGHAI, China, May 08, 2025 (GLOBE NEWSWIRE) -- Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand retail and delivery platform, today announced that it has called an extraordinary general meeting of shareholders …

Lucinity Featured in Chartis Research FinCrime and Compliance 50 Ranking for 2025
REYKJAVIK, Iceland, May 08, 2025 (GLOBE NEWSWIRE) -- Lucinity has been listed among the top 50 Financial Crime and Compliance (FCC) companies in the 2025 FCC50 ranking by Chartis Research. This recognition reflects Lucinity’s continued ability to deliver …

Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS …

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025
NESS ZIONA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that …

Plus Therapeutics to Participate in the D. Boral Capital Inaugural Global Conference
HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …

Malibu Boats, Inc. Announces Third Quarter Fiscal 2025 Results
LOUDON, Tenn., May 08, 2025 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) today announced its financial results for the third quarter ended March 31, 2025. Third Quarter Fiscal 2025 Highlights Compared to Third Quarter Fiscal 2024: Net sales …

OLYMPIC LEGEND SCOTT HAMILTON TO HEADLINE AT ORIGENCE’S LENDING TECH LIVE ‘25
Irvine, California, May 08, 2025 (GLOBE NEWSWIRE) -- Origence, a leading provider of lending technology solutions, announced Olympic icon Scott Hamilton as a keynote speaker for its Lending Tech Live ’25 conference, scheduled for June 16–18, 2025, at the …

Conavi Medical’s Novasight Hybrid™ System Named “Product Innovation of the Year” at 2025 Minnesota Manufacturing Awards
TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally …

Microbix Schedules Release of Results for Q2 Fiscal 2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure …

Peloton Interactive, Inc. Reports Third Quarter Fiscal 2025 Financial Results
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (Nasdaq: PTON) has announced its financial results for the third quarter of fiscal 2025. Please visit the Peloton investor relations website to view the shareholder letter. Today, the …

Berry Corporation Reports First Quarter 2025 Financial and Operational Results, Reaffirms FY25 Guidance and Announces Quarterly Dividend
DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) today announced its financial and operational results for the first quarter of 2025, as well as a quarterly cash dividend of $0.03 per share. Berry …

Syndax Announces Participation in May Investor Conferences
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, as well as …

Playtika Holding Corp. Reports Q1 2025 Financial Results
Revenue of $706.0 million and Direct-to-Consumer (“DTC”) Revenue of $179.2 million Revenue Increased 8.6% Sequentially and 8.4% Year Over Year DTC Platforms Revenue Increased 2.6% Sequentially and 4.5% Year Over Year HERZLIYA, Israel, May 08, 2025 (GLOBE …